Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumor growth in human cancer cells
✍ Scribed by Brattain, Michael G; Sprague, Eugene A; Luo, Jian; López-Casillas, Fernando; Sun, L-Z; Bandyopadhyay, Abhik; Zhu, Yong; Malik, Shazli N; Kreisberg, Jeffrey
- Book ID
- 110066633
- Publisher
- Nature Publishing Group
- Year
- 2002
- Tongue
- English
- Weight
- 361 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The effects of EGF and TGF‐β1 on the proliferation of 2 ovarian carcinoma cell lines (IGROV1 and OVCCR1) were evaluated. The cell lines were adapted to grow in a restricted serum (0.5%) medium. EGF was required for proliferation of both ovarian cell lines. Low doses of TGF‐β1 inhibited
Transforming growth factor-b (TGF-b1) is a potent negative regulator of cell growth that transduces signals through interactions with type I and II receptors. Abnormal expression and mutational alterations of these receptors have been observed in several human malignancies. In this study, we investi
TGF- is a ubiquitous protein that exhibits a broad spectrum of biological activity. The prokaryotic expression and purification of the extracellular domain of the type II TGF- receptor (TR-II-ED), without the need for fusion protein cleavage and refolding, is described. The recombinant TR-II-ED
## Abstract ## BACKGROUND. The expression of receptor‐binding cancer antigen expressed on SiSo cells (RCAS1) is related significantly to the overall survival of patients with various cancers. RCAS1 reportedly induces apoptotic cell death in peripheral lymphocytes, which may contribute to the escap